£129.97

It has never been this cheap. We have no record of a lower price.

£130 today · cheaper than every other day in the last 3 months

Springer Lung Cancer: Basic and Clinical Aspects: Basic and Clinical Aspects: 28 (Cancer Treatment and Research)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 78 days · 78 data points (no recent data)

Historical
Generating forecast…
£129.97 £123.47 £126.07 £128.67 £131.27 £133.87 £136.47 11 August 2026 30 August 2026 18 September 2026 07 October 2026 27 October 2026
View at Amazon ↗

Price data last checked 13 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 78 days • 1 price levels

Days at Price
78 days 0 20 39 59 78 £130 Days at Price

Price Analysis

Most common price: £130 (78 days, 100.0%)

Price range: £130 - £130

Price levels: 1 different prices over 78 days

Description

Lung cancer is one of the biggest challenges in oncology today. The challenge is due to the recognition of the possibility of prevention in at least 70-80 % of all the cases and the extreme difficulties encountered in the treatment of this neoplasm. Despite the knowledge of prevention measures such as cessation of cigarette smoking the incidence continues to increase in many countries. The increase is particularly notable in females in the west ernized countries where the death rate in females in certain regions sur passes that of breast cancer. Furthermore, in many developing countries lung cancer is now being diagnosed with increasing frequency in both sexes and it is expected to be a major cause of death in those countries later in this century or the beginning of next century if the tobacco consumption will continue its rapid rise. With respect to therapy the 1970'es brought considerable progress in understanding of the clinical behaviour of lung cancer thereby establishing the importance of distinguishing between the major histologic types. Thera peutic advancement was particularly experienced in small cell carcinoma with the introduction of combination chemotherapy after this special dis ease entity among lung cancers was recognized as being a disseminated dis ease in almost all cases at the time of diagnosis. It was expected that the improvement in therapy would have continued in the early 1980'es, not only for small cell lung cancer but also for the other cell types.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
04 October 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)
86% match

Progress and Perspective in the Treatment of Lung Cancer (Medical Radiology)

Springer

£113.76 24 Oct 2026
Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)
84% match

Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)

Springer

£158.19 24 Oct 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
83% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.67 22 Oct 2026
Management of Lung Cancer in Older People
83% match

Management of Lung Cancer in Older People

Springer

£103.27 21 Oct 2026
Molecular Targeted Therapy of Lung Cancer
83% match

Molecular Targeted Therapy of Lung Cancer

Springer

£114.71 27 Oct 2026
The Molecular Genetics of Lung Cancer
83% match

The Molecular Genetics of Lung Cancer

Springer

£80.67 15 Oct 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
83% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£161.26 24 Oct 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
83% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£113.76 29 Oct 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
82% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 23 Oct 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
82% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 22 Oct 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
82% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£149.64 23 Oct 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
82% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£165.38 25 Oct 2026
Management of Lung Cancer in Older People
81% match

Management of Lung Cancer in Older People

Springer

£80.67 21 Oct 2026
Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)
81% match

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Springer

£112.42 13 Sep 2026
Inflammation and Lung Cancer
81% match

Inflammation and Lung Cancer

Springer

£55.25 05 Nov 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
81% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£63.27 23 Oct 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
80% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£163.99 23 Oct 2026
Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)
80% match

Cancer of the Lung: From Molecular Biology to Treatment Guidelines (Current Clinical Oncology)

Humana

£113.76 24 Oct 2026
Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)
80% match

Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)

Springer

£76.42 22 Oct 2026
Lung Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-3 (The Clinics: Internal Medicine, Volume 37-3)
80% match

Lung Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-3 (The Clinics: Internal Medicine, Volume 37-3)

Elsevier

£72.42 26 Oct 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
80% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 23 Oct 2026
Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)
80% match

Lung Cancer and Autoimmune Disorders: 833 (Advances in Experimental Medicine and Biology, 833)

Springer

£73.75 24 Oct 2026
Complications of Cancer Therapy: Best Practices in Prevention and Management
80% match

Complications of Cancer Therapy: Best Practices in Prevention and Management

Springer

£52.80 26 Oct 2026
Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)
80% match

Malignant Melanoma 1: 9 (Cancer Treatment and Research, 9)

Springer

£113.76 26 Oct 2026